DPYD and GOPC |
dihydropyrimidine dehydrogenase |
golgi-associated PDZ and coiled-coil motif containing |
- Pyrimidine catabolism
- Pyrimidine metabolism
- Metabolism of nucleotides
|
|
- (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione
- Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate
- 6-Carboxymethyluracil
- Flavin-Adenine Dinucleotide
- Riboflavin Monophosphate
- Uracil
- 5-Iodouracil
|
|
|
|
DPYD and LXN |
dihydropyrimidine dehydrogenase |
latexin |
- Pyrimidine catabolism
- Pyrimidine metabolism
- Metabolism of nucleotides
|
|
- (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione
- Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate
- 6-Carboxymethyluracil
- Flavin-Adenine Dinucleotide
- Riboflavin Monophosphate
- Uracil
- 5-Iodouracil
|
|
|
|
GRIN2A and PLCG1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
phospholipase C, gamma 1 |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Signaling by the B Cell Receptor (BCR)
- Phospholipase C-mediated cascade
- Signaling by FGFR in disease
- FCERI mediated MAPK activation
- Signaling by EGFRvIII in Cancer
- PLCG1 events in ERBB2 signaling
- DAP12 signaling
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Synthesis of IP3 and IP4 in the cytosol
- Signaling by FGFR1 mutants
- Role of phospholipids in phagocytosis
- Fcgamma receptor (FCGR) dependent phagocytosis
- Signaling by PDGF
- DAP12 interactions
- Inositol phosphate metabolism
- Antiviral mechanism by IFN-stimulated genes
- EGFR interacts with phospholipase C-gamma
- Signaling by ERBB2
- Signaling by EGFR
- TCR signaling
- Signaling by VEGF
- Downstream signal transduction
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Signaling by FGFR mutants
- Frs2-mediated activation
- Adaptive Immune System
- Signalling to ERKs
- Prolonged ERK activation events
- Axon guidance
- DAG and IP3 signaling
- VEGFA-VEGFR2 Pathway
- VEGFR2 mediated cell proliferation
- Downstream signaling of activated FGFR
- Netrin-1 signaling
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Innate Immune System
- Signalling by NGF
- Generation of second messenger molecules
- ISG15 antiviral mechanism
- Interferon Signaling
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- NGF signalling via TRKA from the plasma membrane
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Signaling by FGFR
- PECAM1 interactions
- Cell surface interactions at the vascular wall
- Role of second messengers in netrin-1 signaling
- PLC-gamma1 signalling
- FCERI mediated Ca+2 mobilization
- Constitutive Signaling by EGFRvIII
- Signaling by FGFR1 fusion mutants
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and AP1M1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
adaptor-related protein complex 1, mu 1 subunit |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
- HIV Infection
- Host Interactions of HIV factors
- Golgi Associated Vesicle Biogenesis
- The role of Nef in HIV-1 replication and disease pathogenesis
- Nef mediated downregulation of MHC class I complex cell surface expression
- Clathrin derived vesicle budding
- Lysosome Vesicle Biogenesis
- MHC class II antigen presentation
- trans-Golgi Network Vesicle Budding
- Adaptive Immune System
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and DLGAP1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
discs, large (Drosophila) homolog-associated protein 1 |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and RGS3 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
regulator of G-protein signaling 3 |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and IL16 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
interleukin 16 |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and SPTAN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
spectrin, alpha, non-erythrocytic 1 |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Interaction between L1 and Ankyrins
- Apoptotic cleavage of cellular proteins
- Axon guidance
- Programmed Cell Death
- Apoptotic execution phase
- Nephrin interactions
- L1CAM interactions
- Caspase-mediated cleavage of cytoskeletal proteins
- NCAM signaling for neurite out-growth
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and ARHGAP32 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
Rho GTPase activating protein 32 |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Rho GTPase cycle
- Signaling by Rho GTPases
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and AP4M1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
adaptor-related protein complex 4, mu 1 subunit |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and CASK |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Syndecan interactions
- Nephrin interactions
- Non-integrin membrane-ECM interactions
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and NEDD4 |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Downregulation of ERBB4 signaling
- Antigen processing: Ubiquitination & Proteasome degradation
- ISG15 antiviral mechanism
- Interferon Signaling
- Cytokine Signaling in Immune system
- Class I MHC mediated antigen processing & presentation
- Signaling by ERBB4
- Antiviral mechanism by IFN-stimulated genes
- Adaptive Immune System
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GRIN2A and INADL |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
InaD-like (Drosophila) |
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- CREB phosphorylation through the activation of CaMKII
- CREB phosphorylation through the activation of Ras
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Unblocking of NMDA receptor, glutamate binding and activation
- Ras activation uopn Ca2+ infux through NMDA receptor
- Post NMDA receptor activation events
- Transmission across Chemical Synapses
|
- Cell junction organization
- Cell-cell junction organization
- Tight junction interactions
|
- L-Glutamic Acid
- Glycine
- Meperidine
- Felbamate
- Memantine
- Halothane
- Tenocyclidine
|
|
|
|
GSTA1 and ST3GAL1 |
glutathione S-transferase alpha 1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
- Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)
- Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)
- Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)
- Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)
- Defective UGT1A4 causes hyperbilirubinemia
- Glutathione conjugation
- Metabolic disorders of biological oxidation enzymes
- Phase II conjugation
- Defective UGT1A1 causes hyperbilirubinemia
- Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)
- Biological oxidations
- Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)
- Defective GGT1 causes Glutathionuria (GLUTH)
- Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)
|
- Keratan sulfate/keratin metabolism
- MPS I - Hurler syndrome
- MPS IX - Natowicz syndrome
- Glycosaminoglycan metabolism
- Defective MGAT2 causes MGAT2-CDG (CDG-2a)
- O-linked glycosylation
- Defective CHST14 causes EDS, musculocontractural type
- Myoclonic epilepsy of Lafora
- MPS IIID - Sanfilippo syndrome D
- Defective CHST6 causes MCDC1
- Glycogen storage diseases
- Defective ALG2 causes ALG2-CDG (CDG-1i)
- Keratan sulfate biosynthesis
- Diseases associated with glycosaminoglycan metabolism
- Mucopolysaccharidoses
- Defective ALG3 causes ALG3-CDG (CDG-1d)
- Post-translational protein modification
- Defective EXT2 causes exostoses 2
- Termination of O-glycan biosynthesis
- Synthesis of substrates in N-glycan biosythesis
- Asparagine N-linked glycosylation
- MPS IV - Morquio syndrome A
- Sialic acid metabolism
- Defective MPDU1 causes MPDU1-CDG (CDG-1f)
- Metabolism of carbohydrates
- O-linked glycosylation of mucins
- Diseases associated with N-glycosylation of proteins
- MPS VI - Maroteaux-Lamy syndrome
- MPS IIIB - Sanfilippo syndrome B
- Diseases of glycosylation
- Defective B4GALT7 causes EDS, progeroid type
- Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
- Defective SLC26A2 causes chondrodysplasias
- Defective ALG1 causes ALG1-CDG (CDG-1k)
- Defective MOGS causes MOGS-CDG (CDG-2b)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
- Defective ALG9 causes ALG9-CDG (CDG-1l)
- Defective PAPSS2 causes SEMD-PA
- Defective MAN1B1 causes MRT15
- MPS IIIA - Sanfilippo syndrome A
- Defective ALG11 causes ALG11-CDG (CDG-1p)
- MPS IIIC - Sanfilippo syndrome C
- Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
- MPS II - Hunter syndrome
- Defective CHST3 causes SEDCJD
- Defective B3GAT3 causes JDSSDHD
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Defective RFT1 causes RFT1-CDG (CDG-1n)
- Defective ALG6 causes ALG6-CDG (CDG-1c)
- Defective ALG8 causes ALG8-CDG (CDG-1h)
- Defective CHSY1 causes TPBS
- MPS IV - Morquio syndrome B
- Defective ALG12 causes ALG12-CDG (CDG-1g)
- MPS VII - Sly syndrome
|
- Glutathione
- S-Hydroxycysteine
- 2-Hydroxyethyl Disulfide
- N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine
- Glutathione Sulfonic Acid
- S-Benzyl-Glutathione
- S-Hexylglutathione
|
|
|
|
KCNJ11 and KCNJ2 |
potassium channel, inwardly rectifying subfamily J, member 11 |
potassium channel, inwardly rectifying subfamily J, member 2 |
- Inwardly rectifying K+ channels
- Integration of energy metabolism
- ATP sensitive Potassium channels
- Regulation of insulin secretion
- Potassium Channels
|
- GABA B receptor activation
- Inwardly rectifying K+ channels
- GABA receptor activation
- Activation of G protein gated Potassium channels
- Classical Kir channels
- Activation of GABAB receptors
- Potassium Channels
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- G protein gated Potassium channels
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
- Transmission across Chemical Synapses
|
- Glimepiride
- Ibutilide
- Verapamil
- Levosimendan
- Glyburide
- Diazoxide
- Thiamylal
|
|
|
|
TOP1 and PPP2R2B |
topoisomerase (DNA) I |
protein phosphatase 2, regulatory subunit B, beta |
|
|
- Irinotecan
- Topotecan
- Camptothecin
- Lucanthone
- Sodium stibogluconate
- 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM
- 4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE
|
|
|
|
RARA and HDAC4 |
retinoic acid receptor, alpha |
histone deacetylase 4 |
- Generic Transcription Pathway
- Signaling by Retinoic Acid
- Nuclear Receptor transcription pathway
- Orphan transporters
|
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH1
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
- Adapalene
- Acitretin
- Alitretinoin
- Tazarotene
- Etretinate
- Isotretinoin
- Tamibarotene
|
|
|
|
RARA and PHF8 |
retinoic acid receptor, alpha |
PHD finger protein 8 |
- Generic Transcription Pathway
- Signaling by Retinoic Acid
- Nuclear Receptor transcription pathway
- Orphan transporters
|
- Chromatin modifying enzymes
- Chromatin organization
- HDMs demethylate histones
|
- Adapalene
- Acitretin
- Alitretinoin
- Tazarotene
- Etretinate
- Isotretinoin
- Tamibarotene
|
|
|
|
TUBB and DISC1 |
tubulin, beta class I |
disrupted in schizophrenia 1 |
- Organelle biogenesis and maintenance
- Loss of proteins required for interphase microtubule organization from the centrosome
- Loss of Nlp from mitotic centrosomes
- G2/M Transition
- Assembly of the primary cilium
- Centrosome maturation
- Regulation of PLK1 Activity at G2/M Transition
- Mitotic G2-G2/M phases
- Anchoring of the basal body to the plasma membrane
- Recruitment of mitotic centrosome proteins and complexes
- Cell Cycle, Mitotic
|
|
- Vinorelbine
- Vincristine
- Vinblastine
- Podofilox
- Colchicine
- Epothilone D
- Epothilone B
|
|
|
|
CDK1 and IL3RA |
cyclin-dependent kinase 1 |
interleukin 3 receptor, alpha (low affinity) |
- Phosphorylation of the APC/C
- Signaling by FGFR in disease
- Phosphorylation of Emi1
- Signaling by EGFRvIII in Cancer
- Toll Like Receptor TLR1:TLR2 Cascade
- Toll Like Receptor 5 (TLR5) Cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- MyD88 dependent cascade initiated on endosome
- SOS-mediated signalling
- Mitotic G1-G1/S phases
- SHC-mediated signalling
- Recruitment of mitotic centrosome proteins and complexes
- TRIF-mediated TLR3/TLR4 signaling
- ERK1 activation
- Nuclear Pore Complex (NPC) Disassembly
- APC/C:Cdc20 mediated degradation of mitotic proteins
- Regulation of APC/C activators between G1/S and early anaphase
- ERK1 activation
- APC/C:Cdc20 mediated degradation of Cyclin B
- Signaling by VEGF
- Resolution of Sister Chromatid Cohesion
- Downstream signal transduction
- Signalling to RAS
- Toll Like Receptor 3 (TLR3) Cascade
- Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
- APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
- Interleukin-2 signaling
- Mitotic G2-G2/M phases
- Frs2-mediated activation
- MASTL Facilitates Mitotic Progression
- Axon guidance
- IRS-mediated signalling
- G2/M Transition
- VEGFA-VEGFR2 Pathway
- Activated TLR4 signalling
- VEGFR2 mediated cell proliferation
- GRB2 events in ERBB2 signaling
- Cyclin A/B1 associated events during G2/M transition
- Loss of Nlp from mitotic centrosomes
- MyD88:Mal cascade initiated on plasma membrane
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- NCAM signaling for neurite out-growth
- RAF/MAP kinase cascade
- Signalling to p38 via RIT and RIN
- Innate Immune System
- Condensation of Prometaphase Chromosomes
- Signaling by Insulin receptor
- E2F mediated regulation of DNA replication
- Insulin receptor signalling cascade
- Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
- G0 and Early G1
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- SHC-related events
- Signaling by FGFR
- ARMS-mediated activation
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- E2F-enabled inhibition of pre-replication complex formation
- Regulation of mitotic cell cycle
- Cell Cycle Checkpoints
- Signaling by GPCR
- G2/M Checkpoints
- Mitotic Prophase
- Golgi Cisternae Pericentriolar Stack Reorganization
- FCERI mediated MAPK activation
- Regulation of PLK1 Activity at G2/M Transition
- SHC1 events in ERBB2 signaling
- Signaling by SCF-KIT
- DAP12 signaling
- G1/S Transition
- G1/S-Specific Transcription
- Toll Like Receptor 9 (TLR9) Cascade
- G2/M DNA replication checkpoint
- Signaling by PDGF
- DAP12 interactions
- SHC-related events triggered by IGF1R
- GRB2 events in EGFR signaling
- Signaling by ERBB4
- APC/C-mediated degradation of cell cycle proteins
- Toll Like Receptor 2 (TLR2) Cascade
- Signaling by ERBB2
- Signaling by EGFR
- Signaling by Interleukins
- SHC1 events in ERBB4 signaling
- Toll Like Receptor 4 (TLR4) Cascade
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Condensation of Prophase Chromosomes
- Signaling by Leptin
- Signalling to ERKs
- Mitotic Prometaphase
- Prolonged ERK activation events
- Organelle biogenesis and maintenance
- ERK activation
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Activation of NIMA Kinases NEK9, NEK6, NEK7
- Nuclear Envelope Breakdown
- IGF1R signaling cascade
- Recruitment of NuMA to mitotic centrosomes
- Cyclin B2 mediated events
- Toll Like Receptor TLR6:TLR2 Cascade
- M Phase
- IRS-related events triggered by IGF1R
- MyD88 cascade initiated on plasma membrane
- ERK activation
- Downstream signaling of activated FGFR
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- Signalling by NGF
- SOS-mediated signalling
- G2/M DNA damage checkpoint
- MAP kinase activation in TLR cascade
- SHC-mediated signalling
- Depolymerisation of the Nuclear Lamina
- Assembly of the primary cilium
- Cytokine Signaling in Immune system
- NGF signalling via TRKA from the plasma membrane
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- MyD88-independent cascade
- Anchoring of the basal body to the plasma membrane
- Cell Cycle, Mitotic
- SHC1 events in EGFR signaling
- Loss of proteins required for interphase microtubule organization from the centrosome
- FRS2-mediated cascade
- IRS-mediated signalling
- Centrosome maturation
|
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- GPCR downstream signaling
- Signaling by Interleukins
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
- Indirubin-3\'-Monoxime
- Olomoucine
- Hymenialdisine
- SU9516
- Flavopiridol
- Alsterpaullone
|
|
|
|